GlassScriptPhysician profile
Heidi N Schultz
NPI 1942278569
$1,678.14
in general payments reported to CMS, 2019-2025
11 companies · $512 in 2025
The $512 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $48.64 · 2022: $312 · 2023: $308 · 2024: $497 · 2025: $512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,058 · Education: $259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,058.10 |
| Education | $258.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $969.14 | 2022-2025 | Ilumya |
| Abbvie INC. | $228.72 | 2022-2025 | |
| Galderma Laboratories, L.P. | $183.93 | 2025 | Nemluvio, Aklief |
| Revance Therapeutics, INC. | $87.30 | 2024 | Daxxify |
| Janssen Biotech, INC. | $68.99 | 2023 | Tremfya |
| Allergan, INC. | $65.32 | 2021-2022 | |
| Lilly USA, LLC | $22.81 | 2021 | |
| Journey Medical Corporation | $15.47 | 2024 | |
| Uswm, LLC | $15.36 | 2022 | |
| Organon LLC | $11.93 | 2025 | Vtama |
| Biofrontera INC. | $9.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Schultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.